SCHEMBL13680496

SCHEMBL13680496

Cc1cccc(-c2ccc(C(=O)N(C)C)cc2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 4/20 0.72
HSD17B1 P14061 3/20 0.72
ERN1 O75460 2/20 0.53
CYP1A2 P05177 6/20 0.51
CYP3A4 P08684 5/20 0.51
CYP2C19 P33261 5/20 0.51
ALDH1A1 P00352 5/20 0.51
HPGD P15428 5/20 0.51
HSD17B10 Q99714 4/20 0.51
LMNA P02545 3/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPK1 P28482 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2D6 P10635 2/20 0.51
USP2 O75604 1/20 0.51
ALOX12 P18054 1/20 0.51
ATR Q13535 1/20 0.51
MAPT P10636 2/20 0.50
POLB P06746 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18317091 0.83 HSD17B1 (0.67) HSD17B2HSD17B1ERN1CYP3A4CYP2C9
SCHEMBL17795214 0.83 ERN1 (0.60) HSD17B2HSD17B1ERN1CYP3A4HPGD
SCHEMBL24061101 0.82 HSD17B2 (0.63) HSD17B2HSD17B1ALDH1A1HPGDMAPT
SCHEMBL8364545 0.81 ERN1 (0.51) HSD17B2HSD17B1ERN1CYP1A2CYP3A4
SCHEMBL24732320 0.81 HSD17B2 (0.59) HSD17B2HSD17B1CYP1A2CYP3A4CYP2C19
SCHEMBL2047793 0.81 HPGD (0.63) ERN1CYP1A2CYP3A4ALDH1A1HPGD
SCHEMBL16574187 0.81 ALDH1A1 (0.55) HSD17B2HSD17B1ERN1CYP1A2CYP3A4
SCHEMBL10626283 0.81 ALDH1A1 (0.64) ERN1CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL4428711 0.80 MAPT (0.64) HSD17B2HSD17B1ALDH1A1HPGDKDM4E
SCHEMBL2610268 0.80 RXRA (0.69) HSD17B2HSD17B1ALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3865472-A1 THROMBOXANE RECEPTOR ANTAGONISTS ATXA Therapeutics Limited (IE) 2021-08-18 EP disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed